JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martella, V.
Right arrow Articles by Buonavoglia, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martella, V.
Right arrow Articles by Buonavoglia, C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2004, p. 1333-1336, Vol. 42, No. 3
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.3.1333-1336.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

A Canine Parvovirus Mutant Is Spreading in Italy

Vito Martella,1* Alessandra Cavalli,1 Annamaria Pratelli,1 Giancarlo Bozzo,1 Michele Camero,1 Domenico Buonavoglia,2 Donato Narcisi,1 Maria Tempesta,1 and Canio Buonavoglia1

Department of Animal Health and Wellbeing, University of Bari, Bari,1 Department of Pathology and Infectious Diseases, University of Messina, Messina, Italy2

Received 13 December 2002/ Returned for modification 26 May 2003/ Accepted 11 November 2003


   ABSTRACT
Top
 Abstract
Introduction
 References
 
By antigenic and genetic characterization of canine parvovirus type 2 (CPV-2) strains collected in 2001 and 2002 in Italy, it was possible to observe the spread of viruses with an unusual mutation, Glu-426, affecting a major antigenic epitope of CPV-2. Out of 67 strains analyzed, 49 (73.13%) were characterized as CPV-2a, 6 (8.95%) were characterized as CPV-2b, and 12 (17.91%) were characterized as the Glu-426 mutant.


   INTRODUCTION
Top
 Abstract
 Introduction
References
 
In the early 1970s, a new infectious disease with a high rate of mortality was observed in pups throughout the world, and a novel parvovirus was isolated in both canine and feline cell cultures (2, 7, 14, 15). The virus was referred to as canine parvovirus type 2 (CPV-2) to distinguish it from the unrelated parvovirus minute virus of canines (MVC or CPV-1) (8, 9).

CPV-2 possesses a single-stranded DNA genome of about 5,200 nucleotides in length, enclosed in a 26-nm-diameter icosahedral capsid made up of a combination of two proteins, VP1 and VP2 (1, 25). By sequence analysis, CPV-2 has been shown to be closely related to feline panleukopenia virus, from which it presumably originated, and also to parvoviruses from raccoons, minks, and arctic foxes, all of which are included in the feline parvovirus subgroup (20, 33). A few years after the emergence of CPV-2, two new antigenic types, designated type 2a and type 2b and distinguishable by means of monoclonal antibodies (MAbs), arose consecutively (21, 23). Currently, the antigenic variants of CPV have completely replaced the original type 2 virus and are variously distributed in canine populations worldwide (2, 4, 11, 12, 15, 24, 26, 28, 29, 32, 34).

Following the onset and rapid spread of the antigenic variants CPV-2a and CPV-2b, there has been little evidence for a further significant evolution, even if some unusual mutations, such as 300-Asp or 265-Pro, have been described sporadically and another mutation, Ala-297, is now detectable in most of the recent CPV strains irrespective of their antigenic type and geographical origin (3, 13, 29, 32, 34).

Analysis of CPV strains detected in Italy revealed the onset in 2000 of an unusual CPV-2 mutant (5), with a change (Asp-426 to Glu) occurring in the strategic residue 426 (1, 21, 30) (Table 1). The mutation, although affecting an important antigenic epitope of CPV-2, is not identifiable by a panel of MAbs used commonly to characterize CPV strains antigenically, as the Glu-426 mutant displays the same monoclonal reactivity as CPV-2b (5), i.e., they are not recognized by MAb B4A2 (Table 2). However, since the nucleotide variation responsible for the substitution Asp-426 or Asn-426 to Glu at nucleotide 4064 created a new MboII restriction site (GAAGA) unique to these strains, it is possible to distinguish easily the Glu-426 mutants from other antigenic types by restriction enzyme analysis (5).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Amino acid changes in the VP2 capsid protein of reference parvoviruses of the feline subgroupa

 

View this table:
[in this window]
[in a new window]
  		TABLE 2. Reactivities of MAbs against CPV-2, CPV-2a, CPV-2b, and the Glu-426 CPV-2 mutants by hemagglutination inhibition

 
By combining antigenic and genetic analyses, searches for CPVs displaying the Glu-426 mutation were conducted in different parts of Italy (Apulia, Sicily, and Campania) between 2001 and 2002. A total of 67 CPV strains were detected by a hemagglutination assay in either specimens or rectal swabs of pups affected by gastroenteritis. Attempts to adapt the CPV strains to in vitro cultivation in A-72 cells were made. The viruses identified underwent antigenic characterization in a hemagglutination inhibition assay using a panel of four MAbs (A4E3, B4A2, C1D1, and B4E1), kindly supplied by C. R. Parrish (Cornell University, Ithaca, N.Y.). The differential reactivity of CPV-2, CPV-2a, and CPV-2b to MAbs is shown in Table 2. All the strains characterized as type 2b by MAb analysis were subjected to genetic screening by restriction enzyme analysis. The PCR product generated with the primer pair 555for-555rev, corresponding to the COOH terminus of CPV open reading frame 2, was digested with the restriction enzyme MboII (5). To verify the accuracy of MboII digestion, the amplicons 555for-555rev were directly sequenced by using a BigDye sequencing kit and an ABI-377 automatic DNA sequencer (Applied Biosystems, Foster City, Calif.).

In 2001 and 2002, type 2a was the most common antigenic type. Three type 2b CPVs were detected in 2001 and three were detected in 2002. Although in 2000 only two Glu-426 strains had been detected, three strains in 2001 and nine strains in 2002 were identified (Table 3). It is of note that the Glu-426 strains were detected in different areas of southern Italy (Apulia, Sicily, and Campania). Sequence analysis of the strains identified as the Glu-426 mutant by MboII digestion confirmed the presence of the mutation T->A at nucleotide 4064 (data not shown).


View this table:
[in this window]
[in a new window]
  		TABLE 3. Antigenic and genetic characterization of CPV-2 strains in Italya

 
An intriguing question arising from the initial identification of strains 56/00 and 136/00 was whether they represented a newly emerging variant of CPV or a natural mutant detected occasionally. The antigenic variants type 2a and type 2b totally replaced the original CPV-2 and now coexist, even if with different distributions in different countries. In Italy, CPV-2a is prevalent and CPV-2b is isolated with a low frequency (4, 6, 26). The findings of the present study demonstrate that these atypical 56/00- and 136/00-like CPVs are currently cocirculating in Italy together with the other CPV antigenic types.

A peculiarity of parvoviruses of the feline subgroup is that single nucleotide substitutions may determine drastic phenotypic changes affecting antigenicity, host range in vivo and in vitro, and hemagglutination (10, 13, 17, 21, 22, 27, 31, 33). The trajectory of CPV evolution may be considered as a paradigm of how viruses evolve. During its multistep process of evolution, CPV changed its antigenic profile, gained the ability to infect dogs, and lost and regained the ability to infect cats by changing a few amino acid residues (10, 13, 16, 18, 19, 20, 21, 33, 34). From this perspective, the appearance of new variants of CPV-2 as a result of the acquisition of additional changes represents a constant threat to domestic dogs. In recent years, some other CPVs with natural mutations, such as Asp-300 (13) and Pro-265 (3), that significantly affect either the antigenicity or the capsid structure have been identified, but there is no evidence for a further spread of these mutants. In contrast, evidence has now been collected that the Glu-426 mutant of CPV-2 is broadly present in both southern and northern Italy (4). It is therefore possible to speculate that the mutation at residue 426, within an immunodominant epitope of CPV (10, 18, 21, 30), has provided the mutant with a certain benefit.

Continued epidemiological surveillance of the distribution of the CPV types will help elucidate whether this mutant has become permanently established in the dog population and whether it is also spreading in other parts of the world, thus providing insights into the mechanisms driving the evolution of CPV-2.


   ACKNOWLEDGMENTS
 
This work was supported by grants from CEGBA (Centro di Eccellenza di Genomica in campo Biomedico ed Agrario) and from MURST (project "Enteriti dei piccoli animali," Ministero dell'Università per la Ricerca Scientifica e Tecnologica).

We thank Paola Fiorente for expert technical assistance and Athina Papa for editorial suggestions. We are extremely grateful to Leland Eugene Carmichael for constant encouragement throughout the study.


   FOOTNOTES
 
* Corresponding author. Mailing address: Dipartimento di Sanità e Benessere Animale, Facoltà di Medicina Veterinaria di Bari, S.p. per Casamassima km 3, 70010, Valenzano, Bari, Italy. Phone: 39 080 4679833. Fax: 39 080 4679043. E-mail: v.martella{at}veterinaria.uniba.it Back


   REFERENCES
Top
 Abstract
 Introduction
 References
 

  1. Agbandje, M., C. R. Parrish, and M. G. Rossmann. 1995. The recognition of parvovirus capsids by antibodies. Semin. Virol. 6:219-231.
  2. Appel, M. J. G., W. F. Scott, and L. E. Carmichael. 1979. Isolation and immunization studies of canine parvo-like virus from dogs with haemorrhagic enteritis. Vet. Rec. 105:156-159.[Abstract]
  3. Battilani, M., A. Scagliarini, E. Tisato, C. Turilli, I. Jacoboni, R. Casadio, and S. Prosperi S. 2001. Analysis of canine parvovirus sequences from wolves and dogs isolated in Italy. J. Gen. Virol. 82:1555-1560.[Abstract/Free Full Text]
  4. Battilani, M., and S. Prosperi. 2002. Parvovirus del cane: studio molecolare di alcuni ceppi del tipo 2 (CPV-2). Veterinaria 16:65-71.
  5. Buonavoglia, C., V. Martella, A. Pratelli, M. Tempesta, A. Cavalli, D. Buonavoglia, G. Bozzo, G. Elia, N. Decaro, and L. E. Carmichael. 2001. Evidence for evolution of canine parvovirus type-2 in Italy. J. Gen. Virol. 82:3021-3025.[Abstract/Free Full Text]
  6. Buonavoglia, D., A. Cavalli, A. Pratelli, V. Martella, G. Greco, M. Tempesta, and C. Buonavoglia. 2000. Antigenic analysis of canine parvovirus strains isolated in Italy. New Microbiol. 23:93-96.[Medline]
  7. Burtonboy, G., F. Coignoul, P. P. Pastoret, and N. Delferriere. 1979. Canine hemorrhagic enteritis detection of viral particles by electron microscopy. Arch. Virol. 61:1-11.[CrossRef][Medline]
  8. Carmichael, L. E., and L. N. Binn. 1981. New enteric diseases in the dog. Adv. Vet. Sci. Comp. Med. 25:1-37.[Medline]
  9. Carmichael, L. E., D. H. Schlafler, and A. Hashimoto. 1994. Minute virus of canines (MVC, canine parvovirus type-1): pathogenicity for pups and seroprevalence estimate. J. Vet. Diagn. Investig. 6:165-174.[Abstract/Free Full Text]
  10. Chang, S.-F., J.-Y. Sgro, and C. R. Parrish. 1992. Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. J. Virol. 66:6858-6867.[Abstract/Free Full Text]
  11. De Ybanez, R. R., C. Vela, E. Cortes, I. Simarro, and J. I. Casal. 1995. Identification of types of canine parvovirus circulating in Spain. Vet. Rec. 136:174-175.[Medline]
  12. Greenwood, N. M., W. S. K. Chalmers, W. Baxendale, and H. Thompson. 1996. Comparison of isolates of canine parvovirus by monoclonal antibody and restriction enzyme-analysis. Vet. Rec. 138:495-496.[Free Full Text]
  13. Ikeda, Y., M. Mochizuki, R. Naito, K. Nakamura, T. Miyazawa, T. Mikami, and E. Takahashi. 2000. Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPVs in cats. Virology 278:13-19.[CrossRef][Medline]
  14. Johnson, R. H., and P. B. Spradbrow. 1979. Isolation from dogs with severe enteritis of a parvovirus related to feline panleukopaenia virus. Aust. Vet. J. 55:151.
  15. Kelly, W. R. 1978. An enteric disease of dogs resembling feline panleukopaenia virus. Aust. Vet. J. 54:593.[Medline]
  16. Llamas-Sainz, A., M. Agbadje-McKenna, J. S. L. Parker, A. T. M. Wahid, C. R. Parrish, and M. G. Rossmann. 1996. Structural analysis of a mutation in canine parvovirus which controls antigenicity and host range. Virology 225:65-71.[CrossRef][Medline]
  17. Mochizuki, M., R. Harasawa, and H. Nakatani. 1993. Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan. Vet. Microbiol. 38:1-10.[CrossRef][Medline]
  18. Parker, J. S. L., and C. R. Parrish. 1997. Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid. J. Virol. 71:9214-9222.[Abstract]
  19. Parrish, C. R. 1991. Mapping specific functions in the capsid structure of canine parvovirus and feline panleukopenia virus using infectious plasmid clones. Virology 183:195-205.[CrossRef][Medline]
  20. Parrish, C. R. 1999. Host range relationships and the evolution of canine parvovirus. Vet. Microbiol. 69:29-40.[CrossRef][Medline]
  21. Parrish, C. R., C. F. Aquadro, M. L. Strassheim, J. F. Evermann, J.-Y. Sgro, and H. O. Mohammed. 1991. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J. Virol. 65:6544-6552.[Abstract/Free Full Text]
  22. Parrish, C. R., G. Burtonboy, and L. E. Carmichael. 1988. Characterisation of a nonhemagglutinating mutant of canine parvovirus. Virology 163:230-232.[CrossRef][Medline]
  23. Parrish, C. R., P. H. O'Connel, J. F. Evermann, and L. E. Carmichael. 1985. Natural variation of canine parvovirus. Science 230:1046-1048.[Abstract/Free Full Text]
  24. Pereira, C. A., T. A. Monezi, D. U. Mehnert, M. D'Angelo, and E. L. Durigon. 2000. Molecular characterisation of canine parvovirus in Brazil by polymerase chain reaction assay. Vet. Microbiol. 75:127-133.[CrossRef][Medline]
  25. Reed, A. P., E. V. Jones, and T. J. Miller. 1988. Nucleotide sequence and genome organization of canine parvovirus. J. Virol. 62:266-276.[Abstract/Free Full Text]
  26. Sagazio, P., M. Tempesta, D. Buonavoglia, F. Cirone, and C. Buonavoglia. 1998. Antigenic characterisation of canine parvovirus strains isolated in Italy. J. Virol. Methods 73:197-200.[CrossRef][Medline]
  27. Simpson, A. A., V. Chandrasekar V., B. Hebert, G. M. Sullivan, M. G. Rossmann, and C. R. Parrish. 2000. Host range and variability of calcium binding by surface loops in the capsid of canine and feline parvoviruses. J. Mol. Biol. 300:597-610.[CrossRef][Medline]
  28. Steinel, A., E. H. Venter, M. Van Vuuren, C. R. Parrish, and U. Truyen. 1998. Antigenic and genetic analysis of canine parvoviruses in southern Africa. Ondersteeport J. Vet. Res. 65:239-242.
  29. Steinel, A., L. Munson, M. Van Vuuren, and U. Truyen. 2000. Genetic characterization of feline parvovirus sequences from various carnivores. J. Gen. Virol. 81:345-350.[Abstract/Free Full Text]
  30. Strassheim, M. L., A. Gruenberg, P. Veijalainen, J.-Y. Sgro, and C. R. Parrish. 1994. Two dominant neutralizing antigen determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology 198:175-184.[CrossRef][Medline]
  31. Tresnan, D. B., L. Southard, W. Weichert, J.-Y. Sgro, and C. R. Parrish. 1995. Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid. Virology 211:123-132.[CrossRef][Medline]
  32. Truyen, U., A. Steinel, L. Bruckner, H. Lutz, and K. Mostl. 2000. Distribution of antigen types of canine parvovirus in Switzerland, Austria and Germany. Schweiz. Arch. Tierheilkd. 142:115-119.[Medline]
  33. Truyen, U., A. Gruneberg, S. F. Chang, B. Obermaier, P. Veijalainen, and C. R. Parrish. 1995. Evolution of the feline-subgroup of parvoviruses and the control of canine host range in vivo. J. Virol. 69:4702-4710.[Abstract]
  34. Truyen, U., G. Platzer, and C. R. Parrish. 1996. Antigenic type distribution among canine parvoviruses in dogs and cats in Germany. Vet. Rec. 138:365-366.[Free Full Text]

Journal of Clinical Microbiology, March 2004, p. 1333-1336, Vol. 42, No. 3
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.3.1333-1336.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martella, V.
Right arrow Articles by Buonavoglia, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martella, V.
Right arrow Articles by Buonavoglia, C.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS